NRF1 and Miyoshi myopathy: Treatment of MM cells with proteasome inhibitors resulted in NRF1 upregulation, which was shown to be involved in resistance to proteasome inhibitors by ramping up proteasome subunit gene expression and potentially mitochondrial biogenesis [188].